Insider Transactions in Q3 2023 at Nektar Therapeutics (NKTR)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 18
2023
|
Myriam Curet Director |
SELL
Open market or private sale
|
Direct |
4,359
-13.72%
|
$0
$0.69 P/Share
|
|
Sep 18
2023
|
Jeffrey Robert Ajer Director |
SELL
Open market or private sale
|
Direct |
4,359
-11.32%
|
$0
$0.69 P/Share
|
|
Aug 16
2023
|
Howard W Robin President & CEO |
SELL
Open market or private sale
|
Direct |
19,998
-2.13%
|
$0
$0.78 P/Share
|
|
Aug 16
2023
|
Mark Andrew Wilson Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
7,221
-2.8%
|
$0
$0.78 P/Share
|
|
Aug 16
2023
|
Jonathan Zalevsky Chief R&D Officer |
SELL
Open market or private sale
|
Direct |
9,703
-3.31%
|
$0
$0.78 P/Share
|